19395-41-6 | Phenyl(2-piperidinyl)acetic acid

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$26.00	$18.00
1g	98%	in stock	$29.00	$20.00
5g	98%	in stock	$90.00	$63.00
10g	98%	in stock	$163.00	$114.00
25g	98%	in stock	$339.00	$237.00

Description

• Catalog Number: AB52018
• Chemical Name: Phenyl(2-piperidinyl)acetic acid
• CAS Number: 19395-41-6
• Molecular Formula: C13H17NO2
• Molecular Weight: 219.2796
• MDL Number: MFCD06200695
• SMILES: OC(=O)C(c1ccccc1)C1CCCCN1

Computed Properties

• Complexity: 236
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 16
• Hydrogen Bond Acceptor Count: 3
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 3
• Undefined Atom Stereocenter Count: 2
• XLogP3: -2.4

Literature

• Enantioselective determination of methylphenidate and ritalinic acid in whole blood from forensic cases using automated solid-phase extraction and liquid chromatography-tandem mass spectrometry.

  Journal of analytical toxicology 20121001

• Determination of methylphenidate and its metabolite ritalinic acid in urine by liquid chromatography/tandem mass spectrometry.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120115

• Determination of methylphenidate and ritalinic acid in blood, plasma and oral fluid from adolescents and adults using protein precipitation and liquid chromatography tandem mass spectrometry--a method applied on clinical and forensic investigations.

  Journal of pharmaceutical and biomedical analysis 20110715

• HPLC determination of methylphenidate and its metabolite, ritalinic acid, by high-performance liquid chromatography with peroxyoxalate chemiluminescence detection.

  Analytical and bioanalytical chemistry 20110401

• Occurrence and fate of the human pharmaceutical metabolite ritalinic acid in the aquatic system.

  Chemosphere 20101201

• Usefulness of sweat testing for the detection of methylphenidate after fast- and extended-release drug administration: a pilot study.

  Therapeutic drug monitoring 20100801

• Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: potential sources of metabolic drug interactions.

  Toxicology 20100411

• Correlation between methylphenidate and ritalinic acid concentrations in oral fluid and plasma.

  Clinical chemistry 20100401

• Pharmacokinetics of methylphenidate in oral fluid and sweat of a pediatric subject.

  Forensic science international 20100320

• Influence of ethanol on the pharmacokinetics of methylphenidate's metabolites ritalinic acid and ethylphenidate.

  Arzneimittel-Forschung 20100101

• Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice.

  Neuropharmacology 20091201

• Pharmacokinetics, dose-range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 mice.

  Environmental and molecular mutagenesis 20081001

• Liquid chromatography-tandem mass spectrometry method for the simultaneous analysis of multiple hallucinogens, chlorpheniramine, ketamine, ritalinic acid, and metabolites, in urine.

  Journal of analytical toxicology 20071001

• A single-dose, two-way crossover, bioequivalence study of dexmethylphenidate HCl with and without food in healthy subjects.

  Journal of clinical pharmacology 20040201

• Enantioselective analysis of ritalinic acids in biological samples by using a protein-based chiral stationary phase.

  Pharmaceutical research 20031101

• High-throughput selected reaction monitoring liquid chromatography-mass spectrometry determination of methylphenidate and its major metabolite, ritalinic acid, in rat plasma employing monolithic columns.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20030105